Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study

By Westergaard L.G.   Erb K.   Laursen S.B.   Rex S.   Rasmussen P.E.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 543-549

Elsevier

Access to resources Recommend Favorite

Serum Hyperglycosylated Human Chorionic Gonadotropin to Predict the Gestational Outcome in in vitro Fertilization/Intracytoplasmic Sperm Injection Pregnancies

By  

Fetal Diagnosis and Therapy, Vol. 24, Iss. 1, 2008-05 ,pp. : 74-78

Karger

Access to resources Recommend Favorite

Endocrinology. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

By Albano C.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1426-1430

Oxford University Press

Access to resources Recommend Favorite

Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization-embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection

By Elkind-Hirsch K.E.   Bello S.   Esparcia L.   Phillips K.   Sheiko A.   McNichol M.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

Impact of Body Mass Index on Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection Among Polycystic Ovarian Syndrome Patients

By  

Cellular Physiology and Biochemistry, Vol. 39, Iss. 5, 2016-10 ,pp. : 1723-1734

Karger

Access to resources Recommend Favorite